Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Vija Riekstina; V. Leimane; T. H. Holtz; J. Leimans; C. D. Wells

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Vija Riekstina^*
, V. Leimane
, T. H. Holtz
, J. Leimans
, C. D. Wells

^*Corresponding author for this work

State Agency for Tuberculosis and Lung Diseases
State Agency for TB and Lung Diseases of Latvia
Centers for Disease Control and Prevention

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

Original language	English
Pages (from-to)	585-587
Number of pages	3
Journal	International Journal of Tuberculosis and Lung Disease
Volume	11
Issue number	5
Publication status	Published - May 2007
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cohort analysis
Multidrug-resistant tuberculosis
Treatment outcomes
Tuberculosis

Cite this

@article{9577c87ff74f488c83375ae69397378c,

title = "Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia",

abstract = "International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84\%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.",

keywords = "Cohort analysis, Multidrug-resistant tuberculosis, Treatment outcomes, Tuberculosis",

author = "Vija Riekstina and V. Leimane and Holtz, \{T. H.\} and J. Leimans and Wells, \{C. D.\}",

year = "2007",

month = may,

language = "English",

volume = "11",

pages = "585--587",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union Against Tuberculosis and Lung Disease ",

number = "5",

}

TY - JOUR

T1 - Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

AU - Riekstina, Vija

AU - Leimane, V.

AU - Holtz, T. H.

AU - Leimans, J.

AU - Wells, C. D.

PY - 2007/5

Y1 - 2007/5

N2 - International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

AB - International guidelines for treatment outcome analysis of tuberculosis cases have been published and are widely used. They do not, however, fully address the incorporation of multidrug-resistant tuberculosis (MDR-TB) cases. Here we present an approach to cohort analysis of treatment outcomes for all registered TB cases, including MDR-TB cases. We analyzed all new pulmonary smear- and/or culture-positive cases registered in Latvia during 2002. Analysis of treatment outcomes at 24 montbs after initial case registration showed overall treatment success at 84%. This approach to outcome analysis is possible only for settings where MDR-TB treatment is established.

KW - Cohort analysis

KW - Multidrug-resistant tuberculosis

KW - Treatment outcomes

KW - Tuberculosis

UR - https://www.scopus.com/pages/publications/34248380501

M3 - Article

C2 - 17439686

AN - SCOPUS:34248380501

SN - 1027-3719

VL - 11

SP - 585

EP - 587

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 5

ER -

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia

Abstract

UN SDGs

Keywords

Other files and links

Fingerprint

Cite this